Home > Insider Trading > Filing (0000842023-12-000008)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1340652	Chemocentryx Inc.	CCXI	Pharmaceutical Preparations (2834)	943254365

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
842023	Techne Corp /Mn/	614 Mckinley Place Ne Minneapolis MN 55413		No	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2012-02-13	4,713,566	$0.00	4,713,566	No	4	C	Direct
Common Stock	Acquisiton	2012-02-13	1,021,490	$0.00	5,735,056	No	4	C	Direct
Common Stock	Acquisiton	2012-02-13	500,000	$10.00	6,235,056	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	C	Direct
No	4	C	Direct
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Series A Preferred Stock	Disposition	2012-02-13	5,000,000	$0.00	2,500,000	$0.00
Common Stock	Series B Preferred Stock	Disposition	2012-02-13	1,946,836	$0.00	973,418	$0.00
Common Stock	Series C Preferred Stock	Disposition	2012-02-13	1,223,148	$0.00	611,574	$0.00
Common Stock	Series D Preferred Stock	Disposition	2012-02-13	1,257,149	$0.00	628,574	$0.00
Common Stock	Convertible Promissory Note	Disposition	2012-02-13	0	$0.00	1,021,490	$0.00
Common Stock	Warrant	Acquisiton	2012-02-13	150,000	$0.00	150,000	$20.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0			No	4	C	Direct
0			No	4	C	Direct
0			No	4	C	Direct
0			No	4	C	Direct
0			No	4	C	Direct
150,000	2012-02-13	2022-02-12	No	4	A	Direct

Footnotes

The Issuer's Preferred Stock, which had no expiration date, automatically converted to Common Stock at the closing of the Issuer's initial public offering ("IPO") on February 13, 2012 at a conversion ratio of one share of Common Stock for every two shares of Preferred Stock rounded down to the next whole number, for no additional consideration.
The principal amount of the Convertible Promissory Note, plus accrued interest, automatically converted upon the closing of the IPO at a conversion price of $10.00 per share.